An Egg A Day Might Reduce Your Risk Of Heart Disease, Study Says
In this study however, they didn’t assess the risk of developing diabetes, which may be because diabetes is a newer disease in the Chinese population and there is not good documentation of who has it,” Richard said. Still, she noted, “this will be very important data for helping develop dietary prevention guidelines in China.” Cardiovascular disease, which takes the lives of 17.7 million people every year, is the leading cause of death and disability worldwide, according to the World Health Organization. Cardiovascular disease causes nearly a third — 31% — of all global deaths each year....
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 22, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Eggs Heart Disease Local TV Source Type: news

Ultra-Clean Homes Can Raise Childhood Cancer Risk, Study Finds
LONDON (CBS Local) – A groundbreaking study into what triggers cancer has found that children who are “too hygienic” and are kept away from other kids were at greater risk for developing leukemia. The Details: A cancer study has found that children living in ultra-clean environments have higher rates of leukemia Professor Mel Greaves says children need to have their immune system “primed” by exposure to various germs Greaves found that children with siblings or who were breastfed had lower rates of the disease Professor Mel Greaves from the Institute of Cancer Research (ICR) in London h...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 22, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News childhood cancer Children Chris Melore Germs Leukemia Local TV talkers Source Type: news

Blue's Clues: Adding Dye to Colonoscopy May Boost Detection
TUESDAY, May 22, 2018 -- By having patients swallow a blue dye tablet as part of colonoscopy prep, doctors can boost their chances of catching telltale signs of cancer, new research suggests. The dye is technically referred to as " oral... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 22, 2018 Category: General Medicine Source Type: news

U.S. Cancer Death Rate Declines Again, But Prostate Cancer Incidence Rises
TUESDAY, May 22, 2018 -- There's good news for Americans in the war against cancer. Cancer deaths continue to decline nationwide, according to the Annual Report to the Nation on the Status of Cancer. But the report also points to one troubling... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 22, 2018 Category: General Medicine Source Type: news

From 2008 to 2014, Prostate Cancer Testing, Treatment Down
TUESDAY, May 22, 2018 -- Fewer men are being screened for, diagnosed with, and treated for prostate cancer, according to a study published online May 21 in Cancer. James T. Kearns, M.D., from the University of Washington School of Medicine in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 22, 2018 Category: Pharmaceuticals Source Type: news

Medical News Today: What is the difference between a cyst and a tumor?
While cysts and tumors may look and feel similar, there are key differences. Hearing the word “tumor” may be frightening, but many tumors are benign, and while some cysts are harmless, others can cause problems. In this article, learn the difference between cysts and tumors. We also describe conditions that cause them. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 22, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Cancer death rates continue to decline in U.S.
The U.S. continues to see a decline in cancer mortality, according to the latest...Read more on AuntMinnie.comRelated Reading: Lancet: Cancer survival rates improve but vary widely Cancer deaths continue to fall, but CT lung screening lags ACS: U.S. cancer death rates continue to fall JAMA: Cancer deaths fall 20% in U.S. since 1980 ACS report shows cancer rates still falling (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 22, 2018 Category: Radiology Source Type: news

YouTube says natural medicine CBD videos are dangerous to society just like bomb-making videos
(Natural News) In an almost unprecedented move against free speech and the free flow of information, video content giant YouTube has officially shuttered the Natural News channel over a short video, not even one minute long, that explains how CBD oil from the cannabis plant helped a middle-aged woman overcome terminal cancer. The 43-second clip,... (Source: NaturalNews.com)
Source: NaturalNews.com - May 22, 2018 Category: Consumer Health News Source Type: news

Landmark lawsuit claims Monsanto hid cancer danger of weedkiller for decades
In June, a California groundskeeper will make history by taking company to trial on claims it suppressed harm of RoundupAt the age of 46, DeWayne Johnson is not ready to die. But with cancer spread through most of his body, doctors say he probably has just months to live. Now Johnson, a husband and father of three in California, hopes to survive long enough to make Monsanto take the blame for his fate.On 18 June, Johnson will become the first person to takethe global seed and chemical company to trial on allegations that it has spent decades hiding the cancer-causing dangers of its popular Roundup herbicide products &ndash...
Source: Guardian Unlimited Science - May 22, 2018 Category: Science Authors: Carey Gillam Tags: Monsanto California Business Health Cancer Environment US news Farming Agriculture Science World news Source Type: news

GIRFT: Outlier trust stops performing lung cancer procedure
A major teaching hospital has stopped doing a surgical procedure after being identified as an outlier by the Getting It Right First Time programme. (Source: HSJ)
Source: HSJ - May 22, 2018 Category: UK Health Source Type: news

A tricky wrinkle in Trump's Medicare Rx "Blueprint"
Consolidating all Medicare drug payments under Part D sounds easy, but some cancer patients fear they'll take a hit (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 22, 2018 Category: Consumer Health News Source Type: news

Grandmother died after NHS doctors failed to detect bladder cancer  
Pamela North was referred to hospital by her GP with suspected bladder cancer in February 2015. The grandmother from Ilford, Essex, was diagnosed a year later but died in 2016. (Source: the Mail online | Health)
Source: the Mail online | Health - May 22, 2018 Category: Consumer Health News Source Type: news

Health Tip: Why Get a Biopsy
-- A biopsy involves removing bodily tissue to examine it for disease, typically cancer. The procedure also may be used to diagnose other conditions, such as an infection, the Radiological Society of North America says. Some biopsies involve... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 22, 2018 Category: General Medicine Source Type: news

Health Tip: Why Get a Biopsy
Title: Health Tip: Why Get a BiopsyCategory: Health NewsCreated: 5/22/2018 12:00:00 AMLast Editorial Review: 5/22/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 22, 2018 Category: Cancer & Oncology Source Type: news

Chinese investors lead another monster round into this early cancer detection company
Looking to detect cancer early through a simple blood test, Grail Inc. raised a $300 million from several Chinese investors on top of $1.2 billion in two earlier rounds over the past two years. The Menlo Park company, which has been rumored to be planning a $500 million initial public offering in Hong Kong later this year, said the oversubscribed Series C round will help it develop and validate experimental products for early cancer detection. A year ago, it bought Chinese blood diagnos tics company… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 22, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news

SWOG sails into ASCO 2018 on a raft of research results
(SWOG) Researchers from SWOG, a cancer clinical trials group funded by the National Cancer Institute, will participate in 29 presentations to be made at the 54th Annual Meeting of the American Society of Clinical Oncology (ASCO), the world's largest clinical cancer research meeting, which runs June 1-5 in Chicago. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 22, 2018 Category: Cancer & Oncology Source Type: news

Annual Report to the Nation
(NIH/National Cancer Institute) Overall cancer death rates continue to decline in men, women, and children in the United States in all major racial and ethnic groups. Overall cancer incidence, or rates of new cancers, decreased in men and were stable in women from 1999 to 2014. In a companion study, researchers reported an increase in incidence of late-stage prostate cancer and that prostate cancer mortality has stabilized after decades of decline. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 22, 2018 Category: Cancer & Oncology Source Type: news

Studies examine effect of testing frequency after treatment, surgery for colorectal cancer
(JAMA Network) Two studies and a related editorial examined the effect of more or less frequent follow-up testing after treatment or surgery for colorectal cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 22, 2018 Category: Cancer & Oncology Source Type: news

Surveillance intensity not associated with earlier detection of recurrence or improved survival in c
(University of Texas M. D. Anderson Cancer Center) A national retrospective study led by researchers at The University of Texas MD Anderson Cancer Center found no association between intensity of post-treatment surveillance and detection of recurrence or overall survival (OS) in patients with stage I, II or III colorectal cancer (CRC). Published in the Journal of the American Medical Association, the study is the largest of surveillance intensity in CRC ever conducted. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 22, 2018 Category: Cancer & Oncology Source Type: news

Downward-facing mouse: stretching reduces tumor growth in mouse model of breast cancer
(Brigham and Women's Hospital) Using a mouse model of breast cancer and a gentle stretching technique, the team evaluated tumor growth as well as changes in molecular signals of immune response and inflammation resolution. Their results appear in Scientific Reports. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 22, 2018 Category: Cancer & Oncology Source Type: news

UM researcher: Big data, networks identify cell signaling pathways in lung cancer
(The University of Montana) A team of scientists led by University of Montana cell biologist Mark Grimes has identified networks inside lung cancer cells that will help understand this cancer and fight it with drug treatments. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 22, 2018 Category: Cancer & Oncology Source Type: news

'Serendipitous' use of antimalarial drug may have improved outcome for cancer patient
(ecancermedicalscience) A cancer patient with advanced ovarian cancer had a 'remarkable' journey to recovery that may be partially attributed to a treatment she received for a completely different disease, according to a case report published in ecancermedicalscience. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 22, 2018 Category: International Medicine & Public Health Source Type: news

DNA-based vaccine treatment for colorectal cancer to undergo first human study
(Digestive Disease Week) Combining a DNA vaccine, which boosts the body's immune response against tumors, with an antibody that blocks the body's natural defense against the potency of the DNA vaccine, may lead to the development of an effective treatment for late stage colorectal cancer, when a cure is not often possible. Preliminary research leading up to this trial will be presented at Digestive Disease Week ® 2018. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 22, 2018 Category: Cancer & Oncology Source Type: news

Blue dye tablet helps identify polyps during colonoscopy
(Digestive Disease Week) Ingestion of a blue dye tablet during bowel prep for colonoscopy could be a significant advance in the early detection of colorectal cancer (CRC). When used in conjunction with colonoscopy, the blue dye increased adenoma detection rate (ADR) by nearly 9 percent, according to a study scheduled for presentation at Digestive Disease Week ® (DDW) 2018. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 22, 2018 Category: Cancer & Oncology Source Type: news

Blue Earth & #039;s Test Can Play Significant Role in Prostate Cancer Treatment
Topline results seem to give support to Blue Earth Diagnostics’ test to help impact treatment decisions for patients. The Burlington, MA-based company presented results from the LOCATE investigational trial at the American Urology Association’s annual meeting. LOCATE is a prospective, multi-center, open label study conducted at 15 sites in the U.S. The study’s primary endpoint measured the percentage of men with suspected biochemical recurrence of prostate cancer following initial prior therapy whose treatment plan was changed following Blue Earth Diagnostics’ 18F fluciclovine PET/CT scan. The ...
Source: MDDI - May 22, 2018 Category: Medical Devices Authors: Omar Ford Tags: Imaging Source Type: news

Chinese investors lead another monster round into this early cancer detection company
Looking to detect cancer early through a simple blood test, Grail Inc. raised a $300 million from several Chinese investors on top of $1.2 billion in two earlier rounds over the past two years. The Menlo Park company, which has been rumored to be planning a $500 million initial public offering in Hong Kong later this year, said the oversubscribed Series C round will help it develop and validate experimental products for early cancer detection. A year ago, it bought Chinese blood diagnos tics company… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 22, 2018 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Mayo Clinic Minute: Benefits, dangers of fentanyl
Fentanyl?is an?opiate pain medication, that generally is used to treat severe pain, especially for cancer patients.?Fentanyl is 50 to 100 times stronger than morphine, and illegal use of the drug is on the rise, according to the?Centers for Disease Control and Prevention.?Dr. Michael Hooten, a pain management specialist at Mayo Clinic, talks with reporter Vivien [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 22, 2018 Category: Databases & Libraries Source Type: news

In the Loop: ?MelaNoMore? puts a tune to conductor?s cancer journey
Steve Lyon wanted to do something to raise awareness about the melanoma after his diagnosis. So the longtime conductor composed an original piece of music and invited a diverse group of musicians to bring the piece to life. (Image Courtesy Sailor Sun/Hometown Source) Steve Lyon stood at the podium, lifted his hands and began conducting [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 22, 2018 Category: Databases & Libraries Source Type: news

Tuning ITAM multiplicity on T cell receptors can control potency and selectivity to ligand density
The T cell antigen receptor (TCR) recognizes peptides from pathogenic proteins bound in the major histocompatibility complex (MHC). To convert this binding event into downstream signaling, the TCR complex contains immunoreceptor tyrosine-based activation motifs (ITAMs) that act as docking sites for the cytoplasmic tyrosine kinase ZAP-70. Unique among antigen receptors, the TCR complex uses 10 ITAMs to transduce peptide-MHC binding to the cell interior. Using synthetic, drug-inducible receptor-ligand pairs, it was found that greater ITAM multiplicity primarily enhanced the efficiency with which ligand binding was converted ...
Source: Signal Transduction Knowledge Environment - May 22, 2018 Category: Science Authors: James, J. R. Tags: STKE Research Articles Source Type: news

Integration of protein phosphorylation, acetylation, and methylation data sets to outline lung cancer signaling networks
Protein posttranslational modifications (PTMs) have typically been studied independently, yet many proteins are modified by more than one PTM type, and cell signaling pathways somehow integrate this information. We coupled immunoprecipitation using PTM-specific antibodies with tandem mass tag (TMT) mass spectrometry to simultaneously examine phosphorylation, methylation, and acetylation in 45 lung cancer cell lines compared to normal lung tissue and to cell lines treated with anticancer drugs. This simultaneous, large-scale, integrative analysis of these PTMs using a cluster-filtered network (CFN) approach revealed that ce...
Source: Signal Transduction Knowledge Environment - May 22, 2018 Category: Science Authors: Grimes, M., Hall, B., Foltz, L., Levy, T., Rikova, K., Gaiser, J., Cook, W., Smirnova, E., Wheeler, T., Clark, N. R., Lachmann, A., Zhang, B., Hornbeck, P., Maayan, A., Comb, M. Tags: STKE Research Resources Source Type: news

Health Tip: Why Get a Biopsy
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - May 22, 2018 Category: Cancer & Oncology Source Type: news

Blue's Clues: Adding Dye to Colonoscopy May Boost Detection
(Source: Cancercompass News: Colorectal Cancer)
Source: Cancercompass News: Colorectal Cancer - May 22, 2018 Category: Cancer & Oncology Source Type: news

U.S. Cancer Death Rate Declines Again, But Prostate Cancer Incidence Rises
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - May 22, 2018 Category: Cancer & Oncology Source Type: news

Misinformation Rampant Among Cancer Patients
Cancer patients get inundated with advice, how much of it can be trusted? (Source: CancerNetwork)
Source: CancerNetwork - May 21, 2018 Category: Cancer & Oncology Authors: Suzie Siegel Tags: News Source Type: news

Trust pays £10,000 after patient death caused by staff shortages
An NHS trust has paid £10,000 to the family of a woman who died after “delayed and inadequate” investigations left her with terminal cancer. (Source: HSJ)
Source: HSJ - May 21, 2018 Category: UK Health Source Type: news

Why do many women experience breast cancer recurrence after a mastectomy?
(Natural News) If you find out you have breast cancer, your first instinct might be to get rid of it using whatever means possible. Having a mastectomy isn’t a decision any woman takes lightly, of course, but, for many, the idea of sacrificing your breast to be cancer-free seems like a fair trade to make.... (Source: NaturalNews.com)
Source: NaturalNews.com - May 21, 2018 Category: Consumer Health News Source Type: news

New Nomogram Predicts Conditional Probability Of Survival After Gastric Cancer Surgery New Nomogram Predicts Conditional Probability Of Survival After Gastric Cancer Surgery
Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - May 21, 2018 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Keeping babies too clean may trigger leukaemia
Researchers from The Institute of Cancer Research, London, found youngsters who are genetically at-risk of leukaemia are more likely to develop the condition if not exposed to germs. (Source: the Mail online | Health)
Source: the Mail online | Health - May 21, 2018 Category: Consumer Health News Source Type: news

French Twist: ADT for Prostate Cancer on Active Surveillance French Twist: ADT for Prostate Cancer on Active Surveillance
Administering androgen deprivation therapy (ADT) to men with low-risk prostate cancer improves some short-term outcomes. But is it still active surveillance? And do otherwise healthy men need treatment?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 21, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

J & J ’ s Cerenovus wins FDA nod for Embotrap II revascularization device
Johnson & Johnson‘s (NYSE:JNJ) Cerenovus said today it won FDA 510(k) clearance for the Embotrap II revascularization device. The Irvine, Calif.-based J&J division said that the device is designed to quickly restore natural blood flow by retrieving emboli within the vasculature of the brain, using minimal compression to protect against further complications. Approval of the device came based on data from the Arise II study, in which investigators reported being able to restore blood flow in 80% of patients treated within three passes, and in approximately 50% within a single pass. More than 66% of p...
Source: Mass Device - May 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Neurological Regulatory/Compliance Vascular cerenovus johnsonandjohnson Source Type: news

NHS Heroes Awards 2018: Mum raised £2m after son died of cancer - what were his symptoms?
NHS HEROES AWARDS 2018 aired on ITV tonight, and among those leading the tributes were Prince William and the Duchess of Cornwall. One mum was handed an award for raising millions of pounds to fund cancer research after her son lost his three year fight with the disease. The type of cancer he had was rhabdomyosarcoma - what are its symptoms? (Source: Daily Express - Health)
Source: Daily Express - Health - May 21, 2018 Category: Consumer Health News Source Type: news

What's Hot (and Overheated?) at ASCO 2018 What's Hot (and Overheated?) at ASCO 2018
The largest cancer meeting in the world is coming up soon, but early release of abstracts means that data to be presented are already making news.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 21, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

UT Health ’s new hire expected to spawn SA biotech companies
San Antonio is getting more than a world-renowned cancer researcher with the addition of Patrick Sung. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 21, 2018 Category: Biotechnology Authors: W. Scott Bailey Source Type: news

UT Health ’s new hire expected to spawn SA biotech companies
San Antonio is getting more than a world-renowned cancer researcher with the addition of Patrick Sung. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 21, 2018 Category: American Health Authors: W. Scott Bailey Source Type: news

Grandview Cancer Center names new medical director
Grandview Medical Center has named Jennifer De Los Santos as the medical director of the new Grandview Cancer Center.   Dr. De Los Santos has been nationally recognized for her work in radiation oncology, specifically her research in breast cancer treatment. Prior to joining Grandview, she was an associate scientist and professor at the University of Alabama at Birmingham in the department of radiation oncolog y. She also served as medical director of The Kirklin Clinic.  Dr. De Los Santos has… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 21, 2018 Category: Biotechnology Authors: Tyler Patchen Source Type: news

Grandview Cancer Center names new medical director
Grandview Medical Center has named Jennifer De Los Santos as the medical director of the new Grandview Cancer Center.   Dr. De Los Santos has been nationally recognized for her work in radiation oncology, specifically her research in breast cancer treatment. Prior to joining Grandview, she was an associate scientist and professor at the University of Alabama at Birmingham in the department of radiation oncolog y. She also served as medical director of The Kirklin Clinic.  Dr. De Los Santos has… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 21, 2018 Category: American Health Authors: Tyler Patchen Source Type: news

Missing microbes 'cause' childhood cancer
Early exposure to microbes may help protect children against a type of leukaemia, says a UK scientist. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 21, 2018 Category: Consumer Health News Source Type: news

UK government looks to AI to prevent disease, boost industry
The British government is now turning to artificial intelligence as an avenue for early cancer and chronic disease detection. This morning, Prime Minister Theresa May announced plans to invest in AI technology development for the healthcare sector as part of her industrial strategy. The plans aim not only to improve healthcare but to grow the country's AI industry.   (Source: mobihealthnews)
Source: mobihealthnews - May 21, 2018 Category: Information Technology Source Type: news

The Guardian view on AI in the NHS: a good servant, when it ’s not a bad master | Editorial
The NHS collects vast amounts of data. It must be used in imaginative ways that respect privacy and make life better for patients and health workersTechnology helps us live better and for longer; in fact it has been doing so since the birth of modern medicine. And as each new technology comes into use, it turns out to have medical uses, even though these are not always the ones that are sold hardest: in the 1920s the American press was full of advertisements for the health benefits of radium, which was then a mysterious and powerful substance just as artificial intelligence (AI) is today. AI won ’t work miracles or m...
Source: Guardian Unlimited Science - May 21, 2018 Category: Science Authors: Editorial Tags: Artificial intelligence (AI) NHS Data protection UK news Big data Computing Consciousness Technology Health Society Medical research Science Hospitals London Source Type: news

Keeping babies too clean may trigger leukaemia due to their immune systems not being strong enough
Researchers from The Institute of Cancer Research, London, found youngsters who are genetically at-risk of leukaemia are more likely to develop the condition if not exposed to germs. (Source: the Mail online | Health)
Source: the Mail online | Health - May 21, 2018 Category: Consumer Health News Source Type: news